STOCK TITAN

American Oncology Network Stock Price, News & Analysis

AONC OTC

Welcome to our dedicated page for American Oncology Network news (Ticker: AONC), a resource for investors and traders seeking the latest updates and insights on American Oncology Network stock.

American Oncology Network (AONC) delivers physician-led oncology care through a nationwide network of independent practices focused on value-based treatment models. This page provides investors and healthcare stakeholders with timely updates on AONC's operational milestones, financial performance, and community impact.

Access official press releases and curated news covering strategic partnerships, technology integrations like AI-driven diagnostics, and expansions improving cancer care accessibility. Key updates include practice acquisitions, clinical trial advancements, and financial results demonstrating AONC's role in reshaping community oncology.

Bookmark this page for centralized access to AONC's evolving initiatives in care coordination, cost-effective treatment solutions, and partnerships addressing healthcare disparities. Stay informed through verified updates that reflect the network's commitment to operational excellence and patient-centered innovation.

Rhea-AI Summary

American Oncology Network (AON) announced its participation in 14 speaking sessions at the 2025 Community Oncology Alliance (COA) Annual Conference in Orlando, Florida, April 29-30. The conference, themed 'Empower & Advocate: Independent Community Oncology,' will feature AON leaders discussing various aspects of community oncology.

Chief Medical Officer Dr. Stephen Divers and Chief Strategy Officer Alti Rahman will serve as conference co-chairs. Presentations will cover important topics including:

  • Payer contracting and value-based care
  • Clinical trials infrastructure
  • Patient advocacy and mental health programs
  • Radiopharmaceutical therapies
  • Practice partnerships and innovation

The event demonstrates AON's commitment to supporting local practices through comprehensive services including in-house pharmacy, lab services, and back-office operations, enabling physicians to focus on community-based patient care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.17%
Tags
conferences
-
Rhea-AI Summary

American Oncology Network (AON) has reported significant success in the first performance period of the Centers for Medicare & Medicaid Innovation's (CMMI) Enhancing Oncology Model (EOM). The company achieved nearly $6M in cost savings for CMS while earning a performance-based payment and improving patient outcomes.

Building on their previous success in the Oncology Care Model (OCM), where they saw a 2.6% decrease in expenditures, AON practices now represent approximately 10% of the total EOM population. The success was driven by several key initiatives implemented in partnership with Thyme Care, including:

  • Pharmacy interventions focusing on drug waste minimization and therapeutic substitutions
  • 24/7 comprehensive care navigation with virtual support
  • Real-time performance data analytics
  • Virtual palliative care support
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

American Oncology Network (AON) announced the appointment of Anne Marie Rainey, their director of value-based care, to the Association of Cancer Care Centers' Board of Trustees. Rainey, who manages internal quality, government, and value-based care initiatives at AON, brings experience from her work with the Centers for Medicare & Medicaid Services and the Centers for Disease Control and Prevention.

With a Master of Science in Nursing in leadership and administration, Rainey's focus in community oncology includes quality metrics analysis, program implementation, health policy, and community oncology advocacy. The appointment was announced at ACCC's 51st Annual Meeting & Cancer Center Business Summit in March 2025, where new board members were confirmed for two-year terms to advance quality cancer care delivery.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.83%
Tags
none
Rhea-AI Summary

MidAmerica Cancer Care (MACC) has opened a new medical oncology clinic in Kansas City, Kansas at 8919 Parallel Pkwy. The facility features private exam rooms, an infusion room, in-house lab and pathology services, and a specialty pharmacy for oral oncolytics.

The clinic is staffed by board-certified medical oncologists Jaswinder Singh, MD, Nicholas Shuler, DO, Shajadi Patan, MD, and Benjamin Fangman, MD. As a community-based practice, MACC provides affordable cancer care across the Kansas City Metropolitan area and western Missouri.

This expansion follows MACC's recent partnership with American Oncology Network (AON) announced in January, enhancing their service offerings including access to in-house specialty pharmacy with home delivery of certain medications.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4%
Tags
none
-
Rhea-AI Summary

Woodlands Cancer Institute, a partner practice of American Oncology Network (AON), has relocated its medical oncology clinic in The Woodlands, Texas to 18354 I-45 South, Suite 200. The new facility features enhanced amenities including additional private exam rooms, an infusion room, in-house lab and pathology services, and a specialty pharmacy for oral oncolytics.

Board-certified medical oncologists Dr. Eric P. Kleinbaum, Dr. Sandeep Kodityal, and Dr. Krishna K. Pachipala are now accepting patients at the new location. The practice's radiation oncology services will remain at 135 Vision Park Blvd., while the Conroe clinic continues operations at 603 Conroe Medical Drive.

The relocation aims to expand patient services and therapeutics while providing larger space for additional staff. As a community-based practice partnered with AON, Woodlands Cancer Institute offers affordable, personalized cancer care with access to in-house specialty pharmacy services including home medication delivery.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.24%
Tags
none
-
Rhea-AI Summary

American Oncology Network (AON) has launched LabVizor (LV), an advanced cloud-based anatomic pathology laboratory information system developed by SigmaCore. This HIPAA-compliant system, designed specifically for oncologists and pathologists, integrates complex pathology reports into a streamlined, comprehensive system.

LabVizor is the result of over 12 years of development by industry experts, including hematopathologist Dr. Aamir Ehsan and Atiq Malik, Executive Vice President of IT at SigmaCore. The platform is fully integrated with AON's electronic medical record system, enabling bidirectional data exchange.

Key features include:

  • Pre-Accessioning for improved workflow planning
  • Integrated Reporting of complex diagnostic information
  • User-Friendly Dashboard with comprehensive lab operations view
  • Data Analytics supporting clinical guidelines
  • Collaboration Tools for effective workflow management

This integration aligns with AON's mission to provide efficient, high-quality oncology services and improve patient care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.73%
Tags
none
Rhea-AI Summary

Florida Oncology and Hematology (FOH), a partner practice of American Oncology Network (AON), has announced the addition of Dr. Michele Ramirez to their physician team. Dr. Ramirez, a Board-certified medical oncologist and hematologist with over 20 years of experience, will be accepting patients at Naples Community Hospital Baker Hospital Downtown and Naples Community Hospital North Naples Hospital.

Dr. Ramirez earned her medical degree from Cornell University Medical College and completed her residency and fellowship at Case Western Reserve University. She joins FOH's team of eight medical oncologists and 10 advanced practice providers across five Florida locations. The practice offers comprehensive cancer care services including diagnosis, treatment, clinical trials, survivorship, and patient support, all conveniently located close to patients' homes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4%
Tags
none
-
Rhea-AI Summary

MidAmerica Cancer Care (MACC) has joined American Oncology Network (AON), marking a significant expansion in community-based oncology services. MACC, established in 2019, serves the Kansas City metropolitan area and western Missouri with six Board-certified medical oncologists and 16 advanced practitioners.

The partnership aims to enhance MACC's service offerings, including expanded clinical trials and new market opportunities, while maintaining their patient-centered approach. MACC provides comprehensive cancer care services, including diagnostics, treatment, clinical trials, and survivorship programs, featuring private exam rooms and on-site infusion suites.

This collaboration aligns with AON's mission to expand access to high-quality cancer care in local communities and demonstrates their ability to work with both physician groups and hospital systems. The partnership will enable MACC to leverage AON's resources while continuing to deliver personalized cancer care in a community setting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.24%
Tags
none
-
Rhea-AI Summary

Florida Oncology and Hematology, a partner practice of American Oncology Network (AON), has relocated its Fort Myers clinic to 14551 Hope Center Loop. The new state-of-the-art facility features 12 exam rooms, nearly 30 infusion chairs, and an onsite lab.

The expanded clinic provides enhanced services including private exam rooms for patient-physician consultations, infusion services, in-house lab and pathology services, and an onsite specialty pharmacy for oral oncolytics. Board-certified medical oncologists Dr. Magali Van den Bergh, Dr. Venkata Parsa, and Dr. Shivtaj Mann are accepting patients at the new location.

The practice serves patients in Cape Coral, Clearwater, Fort Myers, Naples, and surrounding areas across five clinic locations, offering community-based, affordable cancer care in a comfortable environment with state-of-the-art treatments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

American Oncology Network (AON) has appointed Charlie Goddard as General Counsel. Goddard brings over 15 years of legal experience in healthcare law, corporate governance, and compliance, with expertise in fraud and abuse prevention, data privacy, cyber security, dispute resolution, and high-stakes commercial transactions.

Prior to joining AON, Goddard worked at an AmLaw 100 firm and served as general counsel for a leading orthopedic surgery group. He is a graduate of Florida State University College of Law and is licensed to practice in Florida state courts and the U.S. District Court for the Middle District of Florida.

AON's CEO Todd Schonherz and Chief Medical Officer Dr. Stephen Divers expressed confidence that Goddard's healthcare expertise will help navigate complexities while advancing strategic initiatives as the company continues its growth as one of the nation's fastest-growing community oncology networks.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.35%
Tags
management

FAQ

What is the current stock price of American Oncology Network (AONC)?

The current stock price of American Oncology Network (AONC) is $6.01 as of May 1, 2025.

What is the market cap of American Oncology Network (AONC)?

The market cap of American Oncology Network (AONC) is approximately 17.0M.
American Oncology Network

OTC:AONC

AONC Rankings

AONC Stock Data

17.05M
7.61M
18.8%
0.09%
0.11%
Medical Care Facilities
Services-health Services
Link
United States
FORT MYERS